Combined doxorubicin and alpha-interferon therapy of advanced hepatocellular carcinoma

MLA

Martin Wiesenfeld, et al. “Combined Doxorubicin and Alpha-Interferon Therapy of Advanced Hepatocellular Carcinoma.” Cancer, vol. 71, Apr. 1993, pp. 2187–90. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........0a0c5c2a08081a66886b722ed4907b41&authtype=sso&custid=ns315887.

APA

Martin Wiesenfeld, Michael J. O’Connell, Keith Wright, Carl G. Kardinal, Allan J. Schutt, Charles G. Moertel, James E. Krook, Harry S. Wieand, & Loren K. Tschetter. (1993). Combined doxorubicin and alpha-interferon therapy of advanced hepatocellular carcinoma. Cancer, 71, 2187–2190.

Chicago

Martin Wiesenfeld, Michael J. O’Connell, Keith Wright, Carl G. Kardinal, Allan J. Schutt, Charles G. Moertel, James E. Krook, Harry S. Wieand, and Loren K. Tschetter. 1993. “Combined Doxorubicin and Alpha-Interferon Therapy of Advanced Hepatocellular Carcinoma.” Cancer 71 (April): 2187–90. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........0a0c5c2a08081a66886b722ed4907b41&authtype=sso&custid=ns315887.